Shattuck Labs Inc. (STTK): Price and Financial Metrics
STTK Price/Volume Stats
| Current price | $1.15 | 52-week high | $11.76 |
| Prev. close | $1.04 | 52-week low | $0.94 |
| Day low | $1.02 | Volume | 576,500 |
| Day high | $1.16 | Avg. volume | 439,833 |
| 50-day MA | $1.23 | Dividend yield | N/A |
| 200-day MA | $4.79 | Market Cap | 54.90M |
STTK Stock Price Chart Interactive Chart >
Shattuck Labs Inc. (STTK) Company Bio
Shattuck is a clinical-stage biotechnology company advancing its proprietary Agonist Redirected Checkpoint (ARC) platform, a novel class of dual-function fusion proteins with applications in oncology and autoimmune disease. The company’s lead program, SL-279252 (PD1-Fc-OX40L), is being studied in a Phase I trial in collaboration with Takeda Pharmaceuticals. Its technology focuses on immuno-oncology research targeted towards patients with many cancer types, including melanoma, lung, and bladder, by endowing one molecule with multiple functions, with applicability across the entire spectrum of human disease that enables medical researchers to find a quick and painless detection of malignancy for later-stage cancer patients.
STTK Price Returns
| 1-mo | 13.86% |
| 3-mo | -69.25% |
| 6-mo | -70.92% |
| 1-year | -82.58% |
| 3-year | -86.63% |
| 5-year | N/A |
| YTD | -83.87% |
| 2023 | 210.00% |
| 2022 | -72.97% |
| 2021 | -83.76% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...